Nurse Practitioner in Pine Beach, NJ Accepting Medicare
2 Nurse Practitioner nurses found. Showing 1 - 2
 Lauren Elizabeth Goralski, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1031 Avon Rd, Pine Beach, NJ 08741 Phone: 732-208-8699 |
Mrs. Jennifer Lynn Wolgast, N.P. Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 411 Motor Rd, Pine Beach, NJ 08741 Phone: 732-330-0233 Fax: 732-473-0479 |
News Archive
Pediatricians debunk pearls of medical wisdom
Don't Cross Your Eyes-They'll Get Stuck that Way!, a new book by myth-fighting Indiana University School of Medicine pediatricians Aaron Carroll, M.D., M.S., and Rachel Vreeman, M.D., M.S., debunks the pearls of medical wisdom that many people and even their physicians believe are true. Be prepared to revise your thinking; no, an apple a day won't keep the doctor away and no, warm milk won't help you sleep.
PPMD to fund two promising research initiatives in Duchenne muscular dystrophy
Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today that PPMD will be funding two critical, promising research initiatives in Duchenne.
IVF on the rise in Australia: Report
According to a Federal Government report there are now more births via In Vitro Fertilization (IVF) treatment than ever before in Australia. There has been a 45% rise in the number of babies born through IVF and other treatments between 2004-08, according to the Australian Institute of Health and Welfare report released today. In 2008 there were 10,509 babies born through fertility treatments in Australia.
AbbVie and Myriad Genetics expand Tumor BRACAnalysis CDx collaboration
Myriad Genetics, Inc. announced today that it has signed an expanded companion diagnostic agreement with AbbVie, Inc., a leading global biopharmaceutical company to use Tumor BRACAnalysis CDx™ as a companion diagnostic in support of AbbVie's novel poly (ADP-ribose) polymerase or PARP inhibitor, veliparib.
Finland begins implementation of European biomedical research infrastructures
Finland starts the implementation of European biomedical research infrastructures (BMS ESFRIs) by investing in a national effort called Biomedinfra - a joint effort linking to the EU level initiatives in developing biobanking (BBMRI), bioinformatics (ELIXIR), and translational research (EATRIS) infrastructures. This investment follows the 3-year pan-European planning phase, and a Finnish 2 M€ pilot project for Biomedinfra completed in 2010.
› Verified 7 days ago